A 5-decade analysis of 13,715 carcinoid tumors, Cancer, vol.267, issue.4, pp.934-959, 2003. ,
DOI : 10.1002/cncr.11105
One Hundred Years After ???Carcinoid???: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States, Journal of Clinical Oncology, vol.26, issue.18, pp.3063-3072, 2008. ,
DOI : 10.1200/JCO.2007.15.4377
On behalf of the ESMO guidelines working Group neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann. Oncol, vol.23, pp.124-130, 2012. ,
Tumeurs neuroendocrines du tube digestif et du pancr??as??: ce que le pathologiste doit savoir et doit faire en 2014, Annales de Pathologie, vol.34, issue.1, pp.40-50, 2014. ,
DOI : 10.1016/j.annpat.2014.01.003
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system, ENETS): TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system, pp.395-401, 2006. ,
DOI : 10.1007/s00428-006-0250-1
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system, Virchows Archiv, vol.80, issue.Suppl 4, pp.757-762, 2006. ,
DOI : 10.1007/s00428-007-0452-1
Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors, Modern Pathology, vol.5, issue.2, pp.273-281, 2009. ,
DOI : 10.1385/EP:15:4:275
Liver Metastases of Small Intestine Neuroendocrine Tumors: Ki-67 Heterogeneity and World Health Organization Grade Discordance With Primary Tumors, American Journal of Clinical Pathology, vol.143, issue.3, pp.398-404, 2015. ,
DOI : 10.1309/AJCPQ55SKOCYFZHN
Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor, Neuroendocrinology, vol.103, issue.5, 2015. ,
DOI : 10.1159/000439434
Ki-67 labeling: A more sensitive indicator of malignant phenotype than mitotic count or tumor size?, Journal of Surgical Oncology, vol.23, issue.6, pp.724-727, 2012. ,
DOI : 10.1002/jso.23124
A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms, British Journal of Cancer, vol.115, issue.9, pp.1838-1845, 2013. ,
DOI : 10.1200/JCO.2007.15.4377
Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate, The American Journal of Surgical Pathology, vol.37, issue.11, pp.1671-1677, 2013. ,
DOI : 10.1097/PAS.0000000000000089
Role of Ki-67 Proliferation Index in the Assessment of Patients with Neuroendocrine Neoplasias Regarding the Stage of Disease, World Journal of Surgery, vol.82, issue.1, pp.1353-1361, 2014. ,
DOI : 10.1007/s00268-014-2451-0
A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard, Modern Pathology, vol.52, issue.11, pp.1438-1450, 2013. ,
DOI : 10.1093/jnci/djn326
LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer, Cell Oncol, vol.31, pp.335-343, 2009. ,
The Mitosis-Specific Antibody Anti-Phosphohistone-H3 (PHH3) Facilitates Rapid Reliable Grading of Meningiomas According to WHO 2000 Criteria, The American Journal of Surgical Pathology, vol.28, issue.11, pp.1532-1536, 2004. ,
DOI : 10.1097/01.pas.0000141389.06925.d5
Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index, Journal of Clinical Pathology, vol.59, issue.7, pp.706-710, 2006. ,
DOI : 10.1136/jcp.2005.030452
Can Proliferation Biomarkers Reliably Predict Recurrence in World Health Organization 2003 Defined Endometrial Stromal Sarcoma, Low Grade?, PLoS ONE, vol.31, issue.109, 2013. ,
DOI : 10.1371/journal.pone.0075899.t001
Interobserver Variability of Mitotic Index and Utility of PHH3 for Risk Stratification in Gastrointestinal Stromal Tumors, American Journal of Clinical Pathology, vol.143, issue.3, pp.385-392, 2015. ,
DOI : 10.1309/AJCPAPH28VHZEKNQ
Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds, Neuro-Oncology, vol.17, issue.5, pp.663-669, 2015. ,
DOI : 10.1093/neuonc/nov002
Prognostic comparison of the proliferation markers mitotic activity index, phosphohistone H3, Ki67, steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T 1-2 N 0 M 0 breast cancer, Polish Journal of Pathology, vol.1, pp.1-8, 2013. ,
DOI : 10.5114/pjp.2013.34596
Prognostic Significance of the Mitotic Index Using the Mitosis Marker Anti???Phosphohistone H3 in Meningiomas, American Journal of Clinical Pathology, vol.128, issue.1, pp.118-125, 2007. ,
DOI : 10.1309/HXUNAG34B3CEFDU8
Level of phosphohistone H3 among various types of human cancers, BMJ Open, vol.2, issue.5, p.1071, 2012. ,
DOI : 10.1136/bmjopen-2012-001071